I'm interested in published data regarding the context sensitive half life of propofol at different infusion rates... I believe that there is a limit, below which there is zero accumulation. But I don't know that limit.
-
CycleTrack and SDN are teaming up to make medical school admissions more transparent and accessible! Read the announcement to learn how we’re supporting the future of CycleTrack’s free application-tracking tools .
Propofol context sensitive half life
Started by Soparklion
Get help with your application
Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.
D
deleted697535
Have you searched any of this? There's lots published on this.
And what do you mean by different infusion rates? Csht's definition implies steady state not increasing or decreasing infusions
I have 20 mins in my head for propofol csht but thats UK anesthesia and we're usually drunk and haven't a notion what's going on
And what do you mean by different infusion rates? Csht's definition implies steady state not increasing or decreasing infusions
I have 20 mins in my head for propofol csht but thats UK anesthesia and we're usually drunk and haven't a notion what's going on
Already done by many people. What is your angle that would be different?
Propofol has a context-sensitive half-time that varies between 3 min for a very short infusion to about 18 min after a 12-h infusion. This relatively small variation in context-sensitive half-time, despite a large V3, occurs because excretion is rapid compared with redistribution
academic.oup.com
Pharmacokinetics of drug infusions
Abstract. In clinical practice, drugs are given by continuous infusion to maintain a predictable pharmacodynamic action. In anaesthesia, the most common ro
academic.oup.com
Propofol
Pharmacology
Propofol is distributed rapidly and induces sedation within 30 to 60 seconds. The context-sensitive half-life is only 2 to 8 minutes. Metabolism is by hepatic conjugation with renal excretion of inactive metabolites. Propofol is a centrally acting neural depressant without any analgesic properties and rapidly crosses the blood-brain barrier to potentiate GABA activity.
www.sciencedirect.com
Pharmacology
Propofol is distributed rapidly and induces sedation within 30 to 60 seconds. The context-sensitive half-life is only 2 to 8 minutes. Metabolism is by hepatic conjugation with renal excretion of inactive metabolites. Propofol is a centrally acting neural depressant without any analgesic properties and rapidly crosses the blood-brain barrier to potentiate GABA activity.
Context-Sensitive Half-Life - an overview | ScienceDirect Topics
Not quite sure what you're asking, maybe this helps though:
There is no mathematical "limit" (floor effect) when it comes to the CSHT of propofol, because by definition CSHT is a PK model where the infusion of any amount of drug will produce a positive value (>0 time units). Unless you're actually measuring plasma concentration and not modelling it, in which case, why? Doesn't seem to have any clinical application?
From a clinical perspective: The CSHT is dependent on the effect-site concentration that is being targetted. I assume this is what you're talking about re: lowest infusion rate where the effect-site concentration will approach 0/awake independent of the context (time/duration) of the infusion?
From that, it depends if you want the CSHT of propofol for hypnosis; or the CSHT of propofol for amnesia; or the CSHT of propofol for anxiolysis, etc, etc. You won't find any published data on this because it is too broad and irrelevant when you can do a standardised, high concentration model, and then extrapolate from there. The existing studies only really assess the CSHT of propofol for "MAC" equivalency/BIS scores.
Have a play around with this: Effect Site Concentrations to see if it answers your question.
There is no mathematical "limit" (floor effect) when it comes to the CSHT of propofol, because by definition CSHT is a PK model where the infusion of any amount of drug will produce a positive value (>0 time units). Unless you're actually measuring plasma concentration and not modelling it, in which case, why? Doesn't seem to have any clinical application?
From a clinical perspective: The CSHT is dependent on the effect-site concentration that is being targetted. I assume this is what you're talking about re: lowest infusion rate where the effect-site concentration will approach 0/awake independent of the context (time/duration) of the infusion?
From that, it depends if you want the CSHT of propofol for hypnosis; or the CSHT of propofol for amnesia; or the CSHT of propofol for anxiolysis, etc, etc. You won't find any published data on this because it is too broad and irrelevant when you can do a standardised, high concentration model, and then extrapolate from there. The existing studies only really assess the CSHT of propofol for "MAC" equivalency/BIS scores.
Have a play around with this: Effect Site Concentrations to see if it answers your question.
What you should study, which has not been elucidated well, is how multi drugs effect this multi-compartment model.
In other words, does adding precedex change the pharmacokinetics of propofol? Or visa Versa?
In other words, does adding precedex change the pharmacokinetics of propofol? Or visa Versa?
